Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)
TWD 31.05
(0.81%)
TWD 31.05
(0.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 74.51 Million | 214.85 Million | 139.32 Million | 143.53 Million | 162.95 Million |
| Net Income | 68.67 Million | 137 Million | 104.83 Million | 81.42 Million | 97.25 Million |
| Depreciation & Amortization | 61.95 Million | 72.87 Million | 79.07 Million | 84.14 Million | 82.52 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -19.14 Million | 25.45 Million | -19.34 Million | 5.4 Million | -5.42 Million |
| Other non-cash items | -36.96 Million | 5.19 Million | 115 Thousand | 513 Thousand | 2.69 Million |
| Investing Cash Flow | -76.61 Million | 63.24 Million | -289.01 Million | -20.56 Million | -36.67 Million |
| Investments in PPE | -101.49 Million | -105.85 Million | -265.5 Million | -22.78 Million | -36.89 Million |
| Acquisitions | 410 Thousand | 168.96 Million | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 1.36 Million | - | - |
| Other Investing Activities | 24.88 Million | 57 Thousand | -24.99 Million | 2.18 Million | 224 Thousand |
| Financing Cash Flow | -73.11 Million | -74.88 Million | 66.67 Million | -63.43 Million | -73.9 Million |
| Debt repayment | -5.64 Million | -10 Million | -130 Million | - | -35 Million |
| Dividends payments | -68.38 Million | -56.98 Million | -56.98 Million | -56.98 Million | -34.18 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | 919 Thousand | -869 Thousand | 121 Thousand | -10 Thousand | 1.01 Million |
| Accounts receivables | -26.6 Million | -1.97 Million | - | - | - |
| Accounts payables | -16.48 Million | 17.5 Million | - | - | - |
| Inventory | 9.85 Million | -8.82 Million | -4.86 Million | 125 Thousand | -11.49 Million |
| Other working capital | -2.4 Million | 36.25 Million | - | - | - |
| Cash at beginning of period | 456.25 Million | 252.27 Million | 335.8 Million | 275.19 Million | 226 Million |
| Cash at end of period | 381.04 Million | 456.25 Million | 252.27 Million | 335.8 Million | 275.19 Million |
| Capital Expenditure | -101.49 Million | -105.85 Million | -265.5 Million | -22.78 Million | -36.89 Million |
| Effect of forex changes on cash | - | 766 Thousand | -517 Thousand | 1.06 Million | -3.19 Million |
| Net cash flow / Change in cash | -75.2 Million | 203.98 Million | -83.53 Million | 60.6 Million | 49.18 Million |
| Free Cash Flow | -26.97 Million | 109 Million | -126.18 Million | 120.74 Million | 126.05 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 25.75 Million | 28.12 Million | 7.56 Million | 26.75 Million | 25.67 Million | 23.4 Million |
| Depreciation & Amortization | 16.28 Million | 16.79 Million | 16.11 Million | 15.09 Million | 15.4 Million | 15.34 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 65.67 Million | -27.95 Million | 5.51 Million | -48.68 Million | 1.6 Million | 7.43 Million |
| Other non-cash items | -3.52 Million | -3.51 Million | -1.42 Million | -3.24 Million | -3.48 Million | -2.95 Million |
| Investing Cash Flow | -17.04 Million | -27.97 Million | -20.99 Million | -32.15 Million | -24.22 Million | 767 Thousand |
| Investments in PPE | -17.16 Million | -28.53 Million | -22.67 Million | -38.94 Million | -23.96 Million | -16.26 Million |
| Acquisitions | 84 Thousand | - | 279 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 33 Thousand | 456 Thousand | 1.68 Million | 6.65 Million | -260 Thousand | 17.02 Million |
| Financing Cash Flow | -30.92 Million | 9.09 Million | 9000.00 | -9.57 Million | -1.75 Million | -61.78 Million |
| Debt repayment | -30 Million | -10 Million | -910 Thousand | -60 Million | - | -60 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -30 Million | - | 919 Thousand | - | - | - |
| Accounts receivables | 51.78 Million | - | -7.35 Million | - | - | - |
| Accounts payables | 4.26 Million | - | -4.58 Million | - | - | - |
| Inventory | 2.71 Million | 2.85 Million | 4.56 Million | 7.11 Million | -5000.00 | -1.81 Million |
| Other working capital | 4.78 Million | - | 8.3 Million | - | - | - |
| Cash at beginning of period | 379.68 Million | 381.04 Million | 374.26 Million | 438.39 Million | 440.24 Million | 456.25 Million |
| Cash at end of period | 440.61 Million | 379.68 Million | 381.04 Million | 374.26 Million | 438.39 Million | 440.24 Million |
| Capital Expenditure | -17.16 Million | -28.53 Million | -22.67 Million | -38.94 Million | -23.96 Million | -16.26 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 60.92 Million | -1.36 Million | 6.78 Million | -64.12 Million | -1.85 Million | -16 Million |
| Free Cash Flow | 91.73 Million | -11.01 Million | 5.09 Million | -61.33 Million | 165 Thousand | 28.75 Million |
WINA
PHIA
IBT-B
OBGRF
BRM
JMFINANCIL